With war clouds, an oil shock, and market volatility, we focus on Singapore’s defensive sectors and quality blue-chip names. Deployment of funds from MAS’ Equity Market Development Programme could provide some respite in March and April. Key stock picks are CLAR, CLI, CIT, DBS, DFI, KEP, SE, ST, YZJSGD, ASL, CAREIT, CSE, DELFI, FEH, IFAST, UGAI and VALUE.
Top Stories Company Results | Delfi (DELFI SP/BUY/S$0.945/Target: S$1.12) Delfi’s 2025 revenue of US$500m (-0.5% yoy) missed expectations, while core profit fell 20% yoy, despite beating our forecast on lower selling costs. A softer 4Q25 reflects Indonesia sales weakness (-12% yoy), although own brands’ remained resilient (+5% yoy). Gross margin compressed to 26.5% but easing cocoa prices support recovery. Upgrade to BUY with a raised target price of S$1.12. Company Results | Food Empire H...
Greater China Strategy | Hong Kong Budget 2026-27 The 2026-27 Budget marks a shift from deficit spending to structural consolidation, projecting a HK$22.1b surplus (0.6% of GDP) from last year’s HK$67.0b deficit (2% of GDP), which will lift fiscal reserves from 8 months to 10 months of government expenditure. Real GDP growth is projected at 2.5-3.5% yoy, with CPI at 1.7% yoy. Policy prioritises Northern Metropolis and AI investment, while property measures have turned more prudent, raising luxur...
Delfi’s 2025 revenue of US$500m (-0.5% yoy) missed expectations, while core profit fell 20% yoy, despite beating our forecast on lower selling costs. A softer 4Q25 reflects Indonesia sales weakness (-12% yoy), although own brands’ remained resilient (+5% yoy). Gross margin compressed to 26.5% but easing cocoa prices support recovery. Upgrade to BUY with a raised target price of S$1.12.
Top Stories Company Results | Keppel (KEP SP/BUY/S$11.62/Target: S$13.23) The 2025 results were strong with higher recurring income lifting net profit from continuing operations and ROE, alongside a sharply higher dividend including KREIT units. Infrastructure remained the main earnings pillar, while real estate rebounded through capital recycling. Maintain BUY with an upgraded target price of S$13.23. Company Results | Singapore Exchange (SGX SP/HOLD/S$17.64/Target: S$19.16) SGX’s 1HFY26 core ...
Top Stories Company Update | Valuetronics (VALUE SP/BUY/S$0.865/Target: S$1.03) Easing trade war tensions and new customer orders should increase demand. VALUE’s valuation is highly attractive at 12x FY27F PE, a 30% discount vs Singapore peers’ at 16x. Its dividend yield of about 6% is over 100% higher than peers’ average of 1.4%. Net cash position of HK$1.1b is likely to further enhance shareholders’ return. Maintain BUY and target price of S$1.03. Market Spotlight • US stocks were higher on W...
Greater China Company Update | Mao Geping Cosmetics (1318 HK/NOT RATED/HK$83.95) We hosted an NDR group call with Mao Geping. During the 11.11 campaign, the company achieved 32% revenue growth, despite last year’s high base, in line with its internal targets. The company targets a net addition of 30 counters annually, and focuses on just around 50 SKUs with proven market feedback in online channels. In Oct 25, it opened its first self-operated counter in Hong Kong SAR. Looking ahead, it plans...
Top Stories Company Update | Delfi (DELFI SP/HOLD/S$0.815/Target: S$0.82) Cocoa prices have eased sharply but remain elevated, keeping cost pressures high for Delfi. While 3Q25 drove an improvement in 9M25 top-line (+2% yoy), margins stayed soft due to higher promotional spending, forex weakness and high cocoa costs. EBITDA reached only 60% of our forecast, leading to a 20% earnings cut across 2025-27. Maintain HOLD with an unchanged target price of S$0.82. Market Spotlight • US stocks were mix...
Cocoa prices have eased sharply but remain elevated, keeping cost pressures high for Delfi. While 3Q25 drove an improvement in 9M25 top-line (+2% yoy), margins stayed soft due to higher promotional spending, forex weakness and high cocoa costs. EBITDA reached only 60% of our forecast, leading to a 20% earnings cut across 2025-27. Maintain HOLD with an unchanged target price of S$0.82.
KEY HIGHLIGHTS Results Delfi (DELFI SP/HOLD/S$0.715/Target: S$0.82): 1Q25: In line; promotions and cocoa prices weigh on profitability. Frencken Group (FRKN SP/BUY/S$1.13/Target: S$1.40): 1Q25: Results in line; moderate revenue growth outshines peers. TRADERS’ CORNER City Developments (CIT SP): Trading BUY Keppel DC REIT (KDCREIT SP): Trading BUY
GREATER CHINA Results Baidu Inc (9888 HK/HOLD/HK$86.10/Target: HK$91.00) 1Q25: Solid earnings beat, fuelled by AI cloud growth and monetisation visibility. XPeng Inc (9868 HK/BUY/HK$77.55/Target: HK$150.00) 1Q25: Results beat expectations. Maintain BUY with a target price of HK$150.00. INDONESIA Strategy Indonesia’s State Budget Position As Of Apr 25 Surplus returns, mom improvement in revenue collections, spen...
Delfi’s 1Q25 revenue of US$150m (-0.5% yoy) and EBITDA of US$17m (-27% yoy) were in line with expectations, both forming 29% of our full-year forecasts amid festive demand. Revenue dipped on currency depreciation, while margins narrowed on lower operating leverage and higher promotions. Despite high cocoa prices, management remains confident in navigating near-term pressures, backed by a healthy net cash position of US$52m and strong cash flow. Maintain HOLD with a target price of S$0.82.
GREATER CHINA Initiate Coverage JBM Healthcare (2161 HK/BUY/HK$1.82/Target: HK$2.42) Revitalising iconic pharma heritage brands. Results Wharf Real Estate Investment Co (1997 HK/BUY/HK$20.55/Target: HK$23.10) 2024: Underlying net profit met expectation; lower finance costs being key driver of profits amid top-line uncertainties. Update Jiumaojiu International Holdings (9922 HK/HOLD/HK$3.08/Target: HK$3.00) ...
Delfi’s 2024 earnings of US$34m (-27% yoy) missed our expectations, forming 91% of our full-year forecast. This was due to higher-than-expected promotion spending aimed at increasing market share in the competitive environment. A final dividend of 1.18 US cents/share was declared, bringing total 2024 dividend to 3.25 US cents/share (or a decent 6% yield). High cocoa prices continue to pressure profitability. Maintain HOLD with a lower target price of S$0.82 (S$0.86 previously).
GREATER CHINA Sector Sportswear: Diverging consumption trends; uncertainties remain for full-year retail sales. INDONESIA Results Trimegah Bangun Persada (NCKL IJ/BUY/Rp835/Target: Rp1,480): 3Q24: Strongest quarterly earnings after IPO; above expectations. MALAYSIA Results Bumi Armada (BAB MK/BUY/RM0.55/Target: RM0.65): 3Q24: Profit surprised on the upside again. We opine that markets will look beyond legacy impairments, as sentiment will be buoyed by merger rumours and possible non-FPSO contr...
Delfi’s 3Q24 revenue and EBITDA declined to US$118m (-6% yoy) and US$9m (-32% yoy) respectively, with 9M24 revenue and EBITDA forming 77%/61% of our full-year estimates. Excluding forex impact, Indonesia’s sales fell yoy due to lower demand and a 3Q23 agency brand termination. The outlook remains challenging with high cocoa prices and Indonesia’s shrinking middle class. Maintain HOLD with a lifted target price of S$0.86 (S$0.83 previously) as we roll over our valuation base year.
GREATER CHINA Sector Property Management: 1H24 results wrap-up: Moderate growth in 1H24; facing expansion pressure. INDONESIA Update Champ Resto Indonesia (ENAK IJ/BUY/Rp1,065/Target: Rp1,300): 2025 NPAT to grow 38% yoy; to expand three existing brands; maintain BUY. MALAYSIA Sector Oil & Gas: Petronas 1H24: Despite capex catch-up, volume growth is still slowing qoq. We fear more speed bumps ahead (MLNG outage will not look good for Petronas) while negotiating terms with Petros. Update IOI Cor...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.